Cargando…
Recent advances in the development of nanomedicines for the treatment of ischemic stroke
Ischemic stroke is still a serious threat to human life and health, but there are few therapeutic options available to treat stroke because of limited blood-brain penetration. The development of nanotechnology may overcome some of the problems related to traditional drug development. In this review,...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905263/ https://www.ncbi.nlm.nih.gov/pubmed/33718667 http://dx.doi.org/10.1016/j.bioactmat.2021.01.023 |
_version_ | 1783655074519580672 |
---|---|
author | Tian, Xing Fan, Taojian Zhao, Wentian Abbas, Ghulam Han, Bo Zhang, Ke Li, Nan Liu, Ning Liang, Weiyuan Huang, Hao Chen, Wen Wang, Bing Xie, Zhongjian |
author_facet | Tian, Xing Fan, Taojian Zhao, Wentian Abbas, Ghulam Han, Bo Zhang, Ke Li, Nan Liu, Ning Liang, Weiyuan Huang, Hao Chen, Wen Wang, Bing Xie, Zhongjian |
author_sort | Tian, Xing |
collection | PubMed |
description | Ischemic stroke is still a serious threat to human life and health, but there are few therapeutic options available to treat stroke because of limited blood-brain penetration. The development of nanotechnology may overcome some of the problems related to traditional drug development. In this review, we focus on the potential applications of nanotechnology in stroke. First, we will discuss the main molecular pathological mechanisms of ischemic stroke to develop a targeted strategy. Second, considering the important role of the blood-brain barrier in stroke treatment, we also delve mechanisms by which the blood-brain barrier protects the brain, and the reasons why the therapeutics must pass through the blood-brain barrier to achieve efficacy. Lastly, we provide a comprehensive review related to the application of nanomaterials to treat stroke, including liposomes, polymers, metal nanoparticles, carbon nanotubes, graphene, black phosphorus, hydrogels and dendrimers. To conclude, we will summarize the challenges and future prospects of nanomedicine-based stroke treatments. |
format | Online Article Text |
id | pubmed-7905263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-79052632021-03-12 Recent advances in the development of nanomedicines for the treatment of ischemic stroke Tian, Xing Fan, Taojian Zhao, Wentian Abbas, Ghulam Han, Bo Zhang, Ke Li, Nan Liu, Ning Liang, Weiyuan Huang, Hao Chen, Wen Wang, Bing Xie, Zhongjian Bioact Mater Article Ischemic stroke is still a serious threat to human life and health, but there are few therapeutic options available to treat stroke because of limited blood-brain penetration. The development of nanotechnology may overcome some of the problems related to traditional drug development. In this review, we focus on the potential applications of nanotechnology in stroke. First, we will discuss the main molecular pathological mechanisms of ischemic stroke to develop a targeted strategy. Second, considering the important role of the blood-brain barrier in stroke treatment, we also delve mechanisms by which the blood-brain barrier protects the brain, and the reasons why the therapeutics must pass through the blood-brain barrier to achieve efficacy. Lastly, we provide a comprehensive review related to the application of nanomaterials to treat stroke, including liposomes, polymers, metal nanoparticles, carbon nanotubes, graphene, black phosphorus, hydrogels and dendrimers. To conclude, we will summarize the challenges and future prospects of nanomedicine-based stroke treatments. KeAi Publishing 2021-02-20 /pmc/articles/PMC7905263/ /pubmed/33718667 http://dx.doi.org/10.1016/j.bioactmat.2021.01.023 Text en © 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Tian, Xing Fan, Taojian Zhao, Wentian Abbas, Ghulam Han, Bo Zhang, Ke Li, Nan Liu, Ning Liang, Weiyuan Huang, Hao Chen, Wen Wang, Bing Xie, Zhongjian Recent advances in the development of nanomedicines for the treatment of ischemic stroke |
title | Recent advances in the development of nanomedicines for the treatment of ischemic stroke |
title_full | Recent advances in the development of nanomedicines for the treatment of ischemic stroke |
title_fullStr | Recent advances in the development of nanomedicines for the treatment of ischemic stroke |
title_full_unstemmed | Recent advances in the development of nanomedicines for the treatment of ischemic stroke |
title_short | Recent advances in the development of nanomedicines for the treatment of ischemic stroke |
title_sort | recent advances in the development of nanomedicines for the treatment of ischemic stroke |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905263/ https://www.ncbi.nlm.nih.gov/pubmed/33718667 http://dx.doi.org/10.1016/j.bioactmat.2021.01.023 |
work_keys_str_mv | AT tianxing recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT fantaojian recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT zhaowentian recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT abbasghulam recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT hanbo recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT zhangke recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT linan recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT liuning recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT liangweiyuan recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT huanghao recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT chenwen recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT wangbing recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke AT xiezhongjian recentadvancesinthedevelopmentofnanomedicinesforthetreatmentofischemicstroke |